MTOR and fibrodysplasia ossificans progressiva: In addition, mTOR was identified as a mediator of Activin A-induced chondrogenesis, leading to the use of the mTOR inhibitor rapamycin, which showed anti-HO effects in FOP mouse models (Hino et al, 2018, 2017).